Second malignant neoplasms among long-term survivors of Hodgkin's disease: A population-based evaluation over 25 years

Journal of Clinical Oncology

Volumn 20, Issue 16, 2002, Pages 3484-3494

  Dores, Graça M ^a   Metayer, Catherine ^a   Curtis, Rochelle E ^a   Lynch, Charles F ^a   Clarke, E Aileen ^a   Glimelius, Bengt ^a   Storm, Hans ^a   Pukkala, Eero ^a   Van Leeuwen, Flora E ^a   Holowaty, Eric J ^a   Andersson, Michael ^a   Wiklund, Tom ^a   Joensuu, Timo ^a   Van'T Veer, Mars B ^a   Stovall, Marilyn ^a   Gospodarowicz, Mary ^a   Travis, Lois B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER REGISTRY; CANCER RISK; CARCINOGENESIS; DIGESTIVE SYSTEM CANCER; FEMALE; HODGKIN DISEASE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SECOND CANCER; SOLID TUMOR; UTERINE CERVIX CANCER;

ACTUARIAL ANALYSIS; ADULT; AGE DISTRIBUTION; EUROPE; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; NORTH AMERICA; RISK; TIME FACTORS;

EID: 0037102360     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.09.038     Document Type: Article

References (59)

1. Body wars: Effect of friendly fire (cancer therapy)
2. Hodgkin's disease: Complications of therapy and excess mortality
3. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence
4. Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: An international collaborative study among cancer registries
5. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: The relation to age at treatment
6. Second cancer after the treatment for Hodgkin's disease: A report from the International Database on Hodgkin's disease
7. Second cancer risk following Hodgkin's disease: A 20-year follow-up study
8. Long-term complications of treatment and causes of mortality after Hodgkin's disease
9. Second malignancies after treatment of Hodgkin's disease: The influence of treatment, follow-up time, and age
10. Breast cancer and other second neoplasms after childhood Hodgkin's disease
11. Cancer incidence in five continents: Comparability and quality of data
12. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood
13. Hodgkin's disease
14. Controversies in the management of early stage Hodgkin's disease
15. A study of Hodgkin's disease treated by irradiation
16. Radiation therapy in Hodgkin's lymphoma
17. Combination chemotherapy in the treatment of advanced Hodgkin's disease
18. Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP
19. Multiplicative models and cohort analysis
20. Maximum utilization of the life table method in analyzing survival
21. Lung cancer
22. Second cancers following pediatric Hodgkin's disease
23. Gastrointestinal cancer after treatment of Hodgkin's disease
24. Breast cancer after treatment of Hodgkin's disease
25. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958- 1987
26. Radiation dose and second cancer risk in patients treated for cancer of the cervix
27. Second primary cancer after treatment for cervical cancer: An international cancer registries study
28. Cancer following radiotherapy for peptic ulcer
29. Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease
30. Risk of second cancers after treatment for Hodgkin's disease
31. Bone sarcomas linked to radiotherapy and chemotherapy in children
32. Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer
33. Benign and malignant thyroid neoplasms after childhood irradiation for tinea capitis
34. Therapeutic radiation at a young age is linked to secondary thyroid cancer: The Late Effects Study Group
35. Radiation and breast carcinogenesis
36. Lung cancer after Hodgkin's disease
37. Lung cancer after Hodgkin's disease: A nested case-control study of the relation to treatment
38. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease
39. Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: A population-based cohort study in the five Nordic countries: Association of the Nordic Cancer Registries and the Nordic Society of Pediatric Hematology and Oncology
40. Radiation therapy for breast cancer and increased risk for esophageal carcinoma
41. Barrett's esophagus in three children after antileukemia chemotherapy
42. Barrett's esophagus and chemotherapy, a case report
43. Barrett esophagus after chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF): An iatrogenic injury?
44. Influence of esophagojejunostomy on the induction of adenocarcinoma of the distal esophagus in Sprague-Dawley rats by subcutaneous injection of 2,6-dimethylnitrosomorpholine
45. Esophageal and gastric cancers with metastases induced in dogs by N-ethyl-N′-nitro-N-nitrosoguanidine
46. Risk of second malignant neoplasms among long-term survivors of testicular cancer
47. Carcinogenic effect of N-methyl-N′-nitro-N-nitrosoguanidine (MNNG) in European hamsters
48. Cell proliferation and growth of gastric carcinoma induced in inbred Wistar rats by N-methyl-N′-nitro-N-nitrosoguanidine
49. Induction of gastric carcinomas in nonhuman primates by N-ethyl-N′-nitro-N-nitrosoguanidine
50. Second malignancies after Hodgkin's disease: The Munich experience
51. Cancer mortality following radium treatment for uterine bleeding
52. Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma
53. Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood
54. Second cancers after Hodgkin's disease in childhood
55. Estimation of failure probabilities in the presence of competing risks: New representations of old estimators
56. Tissue doses from radiotherapy of cancer of the uterine cervix